Kirkland, United States
Freespira, founded in 2013, offers an innovative approach to mental health treatment with its FDA-cleared at-home therapy designed to reduce or eliminate symptoms of panic attacks and PTSD. The company leverages a 28-day program focused on normalizing respiratory irregularities, providing a drug-free alternative that appeals to health plans, self-insured employers, and the Veteran’s Administration.
Positioned in the healthcare sector, Freespira addresses the critical need for accessible and effective mental health treatments. This solution not only aims to improve patients' quality of life but also presents significant cost-saving opportunities by reducing medical spending and optimizing healthcare resource utilization.
The company recently secured a $22.60M Late VC investment in April 2024, demonstrating strong investor confidence in its growth potential and unique market positioning. Headquartered in the United States, Freespira remains at the forefront of revolutionizing mental health care through its pioneering treatment method.
